Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
Abstract Tescalcin (TESC; also known as calcineurin B homologous protein 3, CHP3) has recently reported as a regulator of cancer progression. Here, we showed that the elevation of TESC in non-small cell lung cancer (NSCLC) intensifies epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ef08a7a1b0645949972a3ac06bfbd68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0ef08a7a1b0645949972a3ac06bfbd68 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0ef08a7a1b0645949972a3ac06bfbd682021-12-02T16:08:02ZTescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH110.1038/s41598-018-29142-x2045-2322https://doaj.org/article/0ef08a7a1b0645949972a3ac06bfbd682018-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-29142-xhttps://doaj.org/toc/2045-2322Abstract Tescalcin (TESC; also known as calcineurin B homologous protein 3, CHP3) has recently reported as a regulator of cancer progression. Here, we showed that the elevation of TESC in non-small cell lung cancer (NSCLC) intensifies epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) properties, consequently enhancing the cellular resistance to γ-radiation. TESC expression and the phosphorylation (consequent activation) of signal transducer and activator of transcription 3 (STAT3) were upregulated in CSC-like ALDH1high cells than in ALDH1low cells sorted from A549 NSCLC cells. Knockdown of TESC suppressed CSC-like properties as well as STAT3 activation through inhibition of insulin-like growth factor 1 receptor (IGF1R), a major signaling pathway of lung cancer stem cells. TESC activated IGF1R by the direct recruitment of proto-oncogene tyrosine kinase c-Src (c-Src) to IGF1Rβ complex. Treatment of IGF1R inhibitor, AG1024, also suppressed c-Src activation, implicating that TESC mediates the mutual activation of c-Src and IGF1R. STAT3 activation by TESC/c-Src/IGF1R signaling pathway subsequently upregulated ALDH1 expression, which enhanced EMT-associated CSC-like properties. Chromatin immunoprecipitation and luciferase assay demonstrated that STAT3 is a potential transcription activator of ALDH1 isozymes. Ultimately, targeting TESC can be a potential strategy to overcome therapeutic resistance in NSCLC caused by augmented EMT and self-renewal capacity.Jei Ha LeeSoo Im ChoiRae Kwon KimEun Wie ChoIn Gyu KimNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-13 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Jei Ha Lee Soo Im Choi Rae Kwon Kim Eun Wie Cho In Gyu Kim Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1 |
description |
Abstract Tescalcin (TESC; also known as calcineurin B homologous protein 3, CHP3) has recently reported as a regulator of cancer progression. Here, we showed that the elevation of TESC in non-small cell lung cancer (NSCLC) intensifies epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) properties, consequently enhancing the cellular resistance to γ-radiation. TESC expression and the phosphorylation (consequent activation) of signal transducer and activator of transcription 3 (STAT3) were upregulated in CSC-like ALDH1high cells than in ALDH1low cells sorted from A549 NSCLC cells. Knockdown of TESC suppressed CSC-like properties as well as STAT3 activation through inhibition of insulin-like growth factor 1 receptor (IGF1R), a major signaling pathway of lung cancer stem cells. TESC activated IGF1R by the direct recruitment of proto-oncogene tyrosine kinase c-Src (c-Src) to IGF1Rβ complex. Treatment of IGF1R inhibitor, AG1024, also suppressed c-Src activation, implicating that TESC mediates the mutual activation of c-Src and IGF1R. STAT3 activation by TESC/c-Src/IGF1R signaling pathway subsequently upregulated ALDH1 expression, which enhanced EMT-associated CSC-like properties. Chromatin immunoprecipitation and luciferase assay demonstrated that STAT3 is a potential transcription activator of ALDH1 isozymes. Ultimately, targeting TESC can be a potential strategy to overcome therapeutic resistance in NSCLC caused by augmented EMT and self-renewal capacity. |
format |
article |
author |
Jei Ha Lee Soo Im Choi Rae Kwon Kim Eun Wie Cho In Gyu Kim |
author_facet |
Jei Ha Lee Soo Im Choi Rae Kwon Kim Eun Wie Cho In Gyu Kim |
author_sort |
Jei Ha Lee |
title |
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1 |
title_short |
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1 |
title_full |
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1 |
title_fullStr |
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1 |
title_full_unstemmed |
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1 |
title_sort |
tescalcin/c-src/igf1rβ-mediated stat3 activation enhances cancer stemness and radioresistant properties through aldh1 |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/0ef08a7a1b0645949972a3ac06bfbd68 |
work_keys_str_mv |
AT jeihalee tescalcincsrcigf1rbmediatedstat3activationenhancescancerstemnessandradioresistantpropertiesthroughaldh1 AT sooimchoi tescalcincsrcigf1rbmediatedstat3activationenhancescancerstemnessandradioresistantpropertiesthroughaldh1 AT raekwonkim tescalcincsrcigf1rbmediatedstat3activationenhancescancerstemnessandradioresistantpropertiesthroughaldh1 AT eunwiecho tescalcincsrcigf1rbmediatedstat3activationenhancescancerstemnessandradioresistantpropertiesthroughaldh1 AT ingyukim tescalcincsrcigf1rbmediatedstat3activationenhancescancerstemnessandradioresistantpropertiesthroughaldh1 |
_version_ |
1718384638269849600 |